Paul researches prostate cancer, with a special focus on genomics, transcriptomics, and the tumor microbiome. He employs advanced spatial and single-cell techniques to map the tumor microenvironment, to identify molecular and cellular interactions that may influence cancer progression. By integrating multi-omic approaches, he seeks to uncover novel biomarkers and therapeutic targets that enhance patient outcomes in prostate cancer
